Increasing
efforts have been made to develop proteins in circulating
extracellular vesicles (EVs) as potential disease markers. It is in
particular intriguing to measure post-translational modifications
(PTMs) such as phosphorylation, preserved and stable in EVs. To facilitate
the quantitative measurement of EV protein phosphorylation for potential
clinical use, a label-free (LF) multiple reaction monitoring (MRM)
strategy is introduced by utilizing a synthetic phosphopeptide set
(phos-iRT) as the internal standards and a local normalization method.
The quantitation method was investigated in terms of its linear dynamic
range, sensitivity, accuracy, precision, and matrix effect, with a
dynamic range spanning from 10 to 1000 ng/mL and an accuracy ranging
from 82.4 to 116.8% for EV samples. Then, the LF-MRM-based local normalization
method was utilized to evaluate and optimize our recently developed
EVTOP method for the enrichment of phosphopeptides from EVs. Finally,
we applied the optimized EV enrichment approach and the LF-MRM-based
local normalization method to quantify phosphopeptides in urine EVs
from patients with prostate cancer (PCa) and healthy individuals,
showcasing the strategy’s superiority in quantifying phosphopeptides
without isotopic internal standards and validating that the method
is generally applicable in MRM-based EV phosphopeptide quantification.